Severe hypertension is an independent risk factor for posterior reversible encephalopathy syndrome post‐hematopoietic cell transplantation in children with thalassemia major

Background Posterior reversible encephalopathy syndrome ( PRES ) is an increasingly recognized serious complication of cyclosporine A ( CSA ) and tacrolimus ( TAC ) use in hematopoietic cell transplantation ( HCT ) recipients. Procedure A retrospective study was carried out, including 84 cases of HCT for TM from January 2012 to January 2017. Eleven cases were diagnosed with PRES . Results The cumulative incidence of PRES was 13.4% (95%...